Sunovion nabs FDA's blessing for seizure drug; Boehringer eyes animal health buyout;

@FiercePharma:  Best-read special report this weekend: Top 10 Patent Losses for 2014. Report | Follow @FiercePharma

@CarlyHFierce:  Rare-disease co. ViroPharma finally snatched up after lots of speculation--Shire gets it for $4.2B. Release | Follow @CarlyHFierce

> Sunovion won FDA approval for its new seizure drug Aptiom (eslicarbazepine) on data showing it reduced the frequency of seizures compared with placebo. Report

> German drugmaker Boehringer Ingelheim is eyeing an expansion in animal health with an offer for the poultry vaccines and feed additives maker Lohmann, Reuters says. Report

> Alexion ($ALXN) said four new trials show its drug Soliris benefits patients with atypical hemolytic uremic syndrome. Report

> A federal appeals court blocked the Affordable Care Act's requirement that employers offer birth-control coverage in employee insurance. Report (sub. req.)

> USPLabs is recalling OxyElit Pro supplements that have been linked to an outbreak of liver illness. Report

> Indonesia's state-owned drugmaker Kimia Farma reportedly has canceled its plan to issue bonds. Report

Medical Device News

@FierceMedDev: Pfizer, marketing partner pay MA fine for ad overstating EpiPen's benefits. More | Follow @FierceMedDev

@MarkHFierce: Novartis is unloading its blood transfusion Dx unit for more than $1.6B PR. Article | Follow @MarkHFierce

@MichaelGFierce: ICYMI: Chinese investors pursue groundbreaking med tech from Canada's MDI. Story | Follow @MichaelGFierce

> Topera rolls out next-gen heart imaging tech in wake of U.S., EU sign-offs. Story

> TB Dx maker Oxford Immunotec prices IPO shares. More

> FDA report: Intuitive's robots beneficial, but training still lacking. News

Biotech News

@FierceBiotech: Shire pays a steep premium to nab ViroPharma in $4.2B deal. More | Follow @FierceBiotech

@JohnCFierce: Just a few weeks ago Zalicus ($ZLCS) did a 6 for one reverse split to get its stock price back into compliance. Oh well. | Follow @JohnCFierce

@DamianFierce: Still-blazing IPO market takes Ultragenyx from "next year" to "right now." News | Follow @DamianFierce

@EmilyMFierce: Japanese Global Health Innovative Technology Fund awards $5.7M in grants for infectious disease vaccine work. Story | Follow @EmilyMFierce

> PhIII judgment day looms for GlaxoSmithKline's heart drug darapladib. Story

> Global biopharma hub strategy doomed Novartis' outlying R&D facility. Article

CRO News

> Cel-Sci demands $50M from inVentiv over alleged trial fraud. More

> Quintiles paid $146.5M for Novella. Article

> Capsugel bets $20M on Bend's commercial manufacturing. Story

> AMRI steers clear of FDA warning letter after years of fixes. Piece

> Covance partners up for biologics safety testing. Story

Biotech IT News

> Scientists increasingly receptive to life science vendors on social media. News

> Open-access genomics database causes hand-wringing in U.K. More

> Catalent creates web-based tool to ease drug delivery tech selection. Story

> BioDatomics pitches open-source, freemium bioinformatics package. Piece

> Advocacy groups crowdsourcing patient views on risk-benefit of drugs. News

And Finally... The iPhone game Plague Inc. has fans at the Centers for Disease Control and Prevention (CDC) for raising public awareness. Report